Skip to main content

TriSalus Life Sciences, Inc.

TLSI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001826667

No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.

Other share classesTLSIW

Q3 2025 vs. Q2 2025

How the institutions holding TriSalus Life Sciences, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of TLSI: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders4656+10
Shares8.47M9.56M+1.09M (+12.9%)
Value$46.2M$44.5M−$1.69M (−3.7%)

New holders (12)

Institutions that held TriSalus Life Sciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to TLSI in Q3 2025
InstitutionSharesValue% of portfolio
CI Private Wealth, LLC75,700$352.0K0.00%
Squarepoint Ops LLC73,706$342.7K0.00%
CWA Asset Management Group, LLC72,000$334.8K0.01%
White Pine Capital LLC59,733$277.8K0.08%
Sequoia Financial Advisors, LLC19,456$90.5K0.00%
Russell Investments Group, Ltd.2,729$12.7K0.00%
FMR LLC256$1.19K0.00%
The PNC Financial Services Group, Inc.65$3020.00%
Essential Partners LLC22$1020.00%
SBI Securities Co., Ltd.2$90.00%
IFP Advisors, Inc1$50.00%
CWM, LLC90$00.00%

Sold out (2)

Institutions that held TriSalus Life Sciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of TLSI in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Susquehanna International Group, LLP20,558$112.0K
Deutsche Bank AG19,288$105.1K